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ABSTRACT
The Cockayne Syndrome Protein B (CSB) plays an essential role in Transcription-
Coupled Nucleotide Excision Repair (TC-NER) by recruiting repair proteins once 
transcription is blocked with a DNA lesion. In fact, CSB-deficient cells are unable to 
recover from transcription-blocking DNA lesions. 5-Aza-2′-deoxycytidine (5-azadC) 
is a nucleoside analogue that covalently traps DNA methyltransferases (DNMTs) onto 
DNA. This anticancer drug has a double mechanism of action: it reverts aberrant 
hypermethylation in tumour-suppressor genes, and it induces DNA damage. We have 
recently reported that Homologous Recombination and XRCC1/PARP play an important 
role in the repair of 5-azadC-induced DNA damage. However, the mechanisms involved 
in the repair of the DNMT adducts induced by azadC remain poorly understood. In 
this paper, we show for the first time the importance of CSB in the repair of azadC-
induced DNA lesions. We propose a model in which CSB initiates a signalling pathway 
to repair transcription blocks induced by incorporated 5-azadC. Indeed, CSB-deficient 
cells treated with 5-azadC show a delay in the repair of trapped DNMT1, increased 
levels of DNA damage and reduced survival.
INTRODUCTION
After millions of years of evolution, cells have evolved 
complex mechanisms to repair DNA breaks and prevent 
mutations. Although it has been known for many years that 
transcriptional stress plays an important role in genomic 
instability [1–5], it was in the mid-eighties when an additional 
DNA repair mechanism associated with transcriptionally 
active genes [6–7] was discovered. This specialized DNA 
repair processes, called Transcription-Coupled Repair 
(TCR), couples RNA polymerase blocks with the efficient 
removal of DNA lesions in the transcribed strand. This 
pathway is considered as a branch of the nucleotide excision 
repair pathway (NER). In humans, mutations in NER lead 
to a variety of DNA repair disorders, including Cockayne 
syndrome (CS), in which there is a deficiency in TCR. Two 
complementation groups of CS, designed CSA and CSB have 
been identified. Cells with mutations in any of these proteins 
cannot resume transcription after the UV-induced blockage of 
RNA polymerase [8, 9].
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CSB is a 168 kDa protein related to the SWI/SNF 
family of ATP-dependent chromatin remodelers; this 
protein has nucleosome remodeling activity and binds 
to core histone proteins in vitro. When transcription 
fork is blocked, CSB protein is recruited and strongly 
interacts with RNA pol II. This protein acts as a chromatin 
remodeling factor displacing nucleosomes and recruiting 
some protein complexes, including the CSA complex, core 
NER factors (XPA, TFIIH, XPG, XPF-ERCC1, and RPA) 
and histone acetyltransferase p300 (that also works as a 
chromatin remodeling factor) [8]. The CSA complex acts 
by ubiquitination and subsequent degradation of CSB, 
Figure 1: 5-azadC induces transcription-coupled DSBs. (A) Experimental schedule followed. AA8 cells were treated for 6h 
with 15 μM of 5-azaC. DRB (30μM) was present during the last 3h. (B) In order to evaluate DNMT1 foci, DNMT1-GFP transfected 
cells were treated as described above, fixed in paraformaldehyde and scored for DNMT1 foci. Cells containing >5 DNMT1 foci were 
scored as positive. (C) Alternatively the number of DNMT1 foci was scored using Image J software. (D) In order to analyze chromosomal 
abnormalities after 5-azadC treatment (50μM), cells were treated with colcemid and metaphase spreads were made as described in the 
material and methods section. The means and SEM of three independent experiments are shown. Data were statistically analyzed using 
Student’s t-test. Data were considered statistically different when P <0.05 (*) or P <0.01 (**).
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RNA pol II, CSA itself and histones [10]. This clearance 
of proteins is needed for DNA repair and subsequent 
resumption of transcription. Apart from its roles in 
transcription coupled nucleotide excision repair (TC-
NER) and chromatin remodeling, CSB is thought to be 
involved in oxidative damage [11], crosslink repair [12], 
telomere maintenance [13], transcription associated DNA 
recombination [14], double strand break repair choice and 
checkpoint activation [15].
5-aza-2′-deoxycytidine (5-azadC), also called 
decitabine, is a cytidine analogue that is incorporated 
randomly in the genome during replication. This drug is 
effective in the treatment of Myelodysplastic Syndromes 
and Acute Myeloid Leukemia (AML), this latter especially 
in elderly patients [16, 17]. Its mechanism of action 
involves the covalent trapping of DNA methyltransferases 
(DNMTs) onto DNA, generating a whole hypomethylation 
state [18]. Therefore, this drug can reactivate the 
expression of Tumour Suppressor Genes whose promoters 
are highly hypermethylated [19]. Trapped DNMTs onto 
DNA generate DNA damage, which also contributes to the 
anticancer properties of this nucleoside [20–22].
The mechanisms involved in the repair of the DNMT 
adducts induced by azadC remain poorly understood. We 
recently reported that these bulky lesions can interfere 
with replication forks and induce double strand breaks 
(DSBs) that are repaired by Homologous Recombination 
(HR) involving Fanconi Anemia (FA) proteins (21). Also, 
we have proposed that XRCC1 and PARP could play a role 
in the repair of DNMT adducts [22]. In the present paper, 
we investigate the role of CSB in the repair of the lesions 
induced by 5-azadC. We show that CSB is important in 
the repair of the lesions induced by 5-azadC in a process 
that is independent of classic TC-NER. We found that a 
transcription coupled DNA damage response (TC-DDR) 
is activated shortly after 5-azadC incorporation in a CSB 
dependent manner. Furthermore, our results revealed that 
CSB-deficient cells displayed a delay in the repair of 
DNMT1 adducts, resulting in hypersensitivity to 5-azadC. 
Finally, we demonstrate that CSB and transcription act in 
the same pathway to repair 5-azadC-induced DNA lesions 
and promote survival.
RESULTS
5-azadC induces transcription-dependent double 
strand breaks
We have recently reported that 5-azadC induces 
DNA damage that depends on active replication, which 
suggests that trapped DNMT collapses with oncoming 
replication forks into DSBs (21). Here we wanted to 
investigate the possible role of transcription elongation in 
the generation of DNA breaks after 5-azadC treatment. In 
order to distinguish between replication and transcription-
associated DNA DSBs, we exposed the cells to 5-azadC 
for 6 h. This short exposure time impossibilities that 
a second round of DNA replication takes place over a 
5-azadC substituted DNA (Figure 1A).
DNA damage was monitored by the scoring of 
chromosome aberrations as indicators of DSBs [23]. 
Cells were co-treated with the transcription inhibitor DRB 
during the last 3 h to see if transcription elongation is 
required for the formation of chromosomal abnormalities. 
Under these conditions, when DNMT1-GFP transfected 
AA8 cells were treated with 5-azadC, they presented 
increased levels of DNMT1 foci as compared to control 
cells (Figure 1B–1C). Of interest, we could not find any 
significant difference in the levels of trapped DNMT1 
between 5-azaC treated and co-treated cells. This data 
indicates that similar levels of the initial lesions are 
present in both cases.
It is worth mentioning that a 6 h treatment with 5-azadC 
induced chromosome aberrations (Figure 1D); this suggests that 
the breaks arising as a consequence of collapsed replications 
forks is not the only mechanism by which 5-azadC induces 
DNA damage. Indeed, transcription inhibition abrogates the 
levels of 5-azadC induced chromosome aberrations (Figure 
1D). Also, we observed that this abrogation was not caused by 
a reduction in the mitotic index (Supplementary Figure 1A) or 
by variations in cell cycle profiles (Supplementary Figure 1B 
and 1C). Furthermore, our experimental schedule is similar to 
other previously published in relation with Topoisomerase I 
adducts [23].
A transcription dependent DNA damage 
response (TC-DDR) is activated after 5-azadC 
incorporation
It has been shown that Topoisomerase I-DNA 
complexes can block transcription forks resulting in the 
activation of a DDR involving ATM-CHK2, γ-H2AX, 
53BP1 and DNA-PK [24, 25]. H2AX is phosphorylated 
at Serine 139 in response to several types of DNA damage 
such as DNA DSBs [26] and replication stress [27]. 
53BP1 foci are a more restrictive marker for DSBs and 
are thought to be indicative of a NHEJ repair [28, 29].
Using the same experimental design described 
above (Figure 1A), we wanted to analyze if a TC-DDR 
is activated. We used human cells defective in CSB 
from a Cockayne syndrome patient complemented with 
human CSB (CS1AN CSB-GFP). According to the results 
presented before, 5-azadC induced an increase in the 
phosphorylation of H2AX which was reduced when cells 
were co-treated with DRB (Figure 2A). Similar results 
were found when examining 53BP1 foci (Figure 2B).
CSB has been recently proposed to have a role in the 
repair of Topoisomerase I cleavable complexes stabilized 
by Camptothecin (CPT) [30]. Under our experimental 
design we found an accumulation of CSB in foci after 
a treatment with 5-azadC that seems to be transcription 
dependent (Figure 2C).
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We found that γ-H2AX co-localized with CSB foci, 
and that the frequency of 5-azadC induced co-localized foci 
was reduced when transcription was inhibited (Figure 2D).
When looking at co-localization in DNMT1-GFP 
transfected cells, we found that DNMT1 foci co-localized 
with γ-H2AX. This data indicates the activation of a DDR 
when 5-azadC was administered at short times without 
the interference of a second replication round (Figure 
2E). Under these conditions, γ-H2AX also co-localized 
with 53BP1 foci (Figure 2F). All these data suggest 
that transcription has a role in the sensing of the lesions 
induced by 5-azadC.
Figure 2: A transcription dependent DNA damage response is activated after 5-azadC incorporation. CS1AN CSB-GFP 
complemented cells were treated following the schedule presented in Figure 1A and γ-H2AX (A), 53BP1 (B) and CSB (C) foci were 
analyzed. The average of γ-H2AX foci colocalizing with CSB per cell is representated in (D). Representative micrographs are depicted in 
(E). (F) Co-localization between DNMT1 and γ-H2AX foci. AA8 cells were transfected with DNMT1-GFP plasmid, treated for 6 h with 
5-azadC and immunomarked for γ-H2AX. (G) Co-localization between 53BP1 and γ-H2AX. AA8 cells were treated for 6 h with 5-azadC 
and cells were fixed and marked for immunofluorescence. Confocal micrographs are depicted. The means and SEM of two-three independent 
experiments are shown. Statistical significance was determined using Student’s t-test, n.s. = non-significant, **P < 0.01, *P < 0.05.
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CSB mutant cells have defects in the signaling of 
DNA damage induced by 5-azadC
Once described that the initial DNA lesions induced 
by 5-azadC are sensed in a transcription dependent 
fashion, we wanted to address the importance of CSB 
in the setup of this process. We use UV61 and CS1AN 
cells (CSB deficient) and data were compared with AA8 
(wild type) or CS1AN CSB-GFP (CSB complemented) 
cells. Cells were treated for 6 hour with 5-azadC and the 
frequency of DNMT1 foci was monitored in wild type and 
CSB deficient cells. Our results showed no difference in 
the number of DNMT1 foci in both cell lines after 5-azadC 
treatment (Figure 3A–3B). Therefore, the frequency of 
initial lesions seems to be similar, which makes possible 
to compare the DDR activated in both cell lines. We found 
that UV61 cells were unable to phosphorylate H2AX 
in response to 5-azadC (Figure 3C). Accordingly, we 
could not find an increase in the co-localization between 
γ-H2AX and DNMT1 in response to 5-azadC in CSB 
mutant cells (Figure 3D).
When we wanted to analyse γ-H2AX and 53BP1 
foci in human cells, a similar pattern was found, which 
demonstrates a similar behaviour of hamster and human 
cells (Figure 3E–3F).
A classical feature of CSB-deficient cells is related 
with its transcriptional incapability to recover from a 
transcription block [8]. In order to monitor the effect of 
5-azadC in the transcription rates, we incubated AA8 
and UV61 cells with increasing doses of 5-azadC for 6 
h. Then, cells were pulse-labelled for 15 minutes with 
3H-Uridine and transcription rates were measured in a 
scintillation counter. Our data shows a consistent decrease 
in transcription rates in UV61 cells from the first dose 
assayed (5μM). However, the block started to be evident 
only when high doses of the drug were assayed for wild 
type cells (Figure 3G). Altogether, our results show that 
CSB is involved in the signaling of 5-azadC lesions 
required to resume transcription.
Delayed repair of trapped DNMT1 in CSB 
mutant cells
Trapped DNMTs are the primary lesion induced by 
5-azadC responsible for tumour cell death [31]. It has been 
recently shown that trapped Topoisomerases by poisons 
are obstacles to transcription, causing blocks that act as 
sensors for the repair of the adducts and the resumption 
of transcription [24]. Moreover CSB has been recently 
implicated in this mechanism [30].
Based on the evidence reported above, our data 
suggests an implication of CSB in the signaling of trapped 
DNMT1. If this is the case, it is conceivable to think that 
CSB deficient cells would be defective in the repair of 
trapped DNMT1 induced by 5-azadC. To address this 
question, we performed cellular fractionation to isolate 
chromatin in which we detected trapped DNMT1. We 
show that DNMT1-GFP transfected AA8 and UV61 cells 
presented similar levels of native and ectopic DNMT1 in 
the whole lysates (Figure 4A).
In order to monitor the repair of trapped DNMT1, 
DNMT1-GFP transfected cells were treated with 15μM 
of 5-azadC for 24 h, washed and allowed to recover for 
different times in drug free media. When looking at the 
levels of remaining DNMT1-GFP trapped in chromatin, 
we found a clear increase in UV61 cells compared to 
wild type cells (Figure 4B). Taking into account that 
there is some repair during the treatment time, a plausible 
explanation would be a defect in the repair in CSB 
deficient cells, responsible for the increased level of 
trapped DNMT1 observed after treatment. Also, we think 
that this repair defect in CSB mutant cells would be the 
cause for the delayed repair observed as well.
This result was confirmed by fluorescence 
microscope in DNMT1-GFP transfected cells (Figure 4D). 
In this case, DNMT1 foci were scored over time after a 
24 hour treatment with 5-azadC. Our data show that CSB 
cells present more DNMT1 foci all along the repair time 
course. These findings agree very well with data presented 
above and highlight the importance that CSB has in the 
repair of trapped DNMT1.
Increased levels of DNA damage and reduced 
survival in CSB mutant cells after 5-azadC 
treatment
Recently, we have shown that trapped DNMTs 
interfere with replication and generate DNA damage [21]. 
If CSB mutant cells have defects in the repair of trapped 
DNMT1, the levels of DNA damage should increase 
over time. To test this hypothesis, we treated cells with 
5-azadC for 24 h and allowed to repair for another 24 h. 
DNA damage was evaluated by the scoring of γ-H2AX, 
53BP1 and RAD51 foci (Figure 5A–5D). We found 
that, in contrast to the data obtained when we used short 
treatments (Figure 2), CSB mutant cells display increased 
levels of DNA damage foci. In our opinion this apparent 
contradiction can be explained considering that foci 
arising after short treatments indicate initial signaling of 
the repair of 5-azadC lesions. On the contrary, many of the 
foci visualized after long treatments could be related with 
the signaling of secondary lesions i.e. collisions with the 
replication fork with trapped DNMT1.
On the other hand, CSB deficient cells showed 
a high increase in 5-azadC induced RAD51 foci as 
compared to wild type cells (Figure 5D). We hypothesize 
that CSB cells could present increased levels of collapsed 
forks as a result of unrepaired DNMT1 triggering RAD51-
dependent HR for repair.
Of interest, CSB deficient cells showed increased 
micronuclei frequency, which is indicative of residual 
DNA breaks (Figure 5E).
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Next we wanted to examine if DNA repair defects 
observed in CSB mutant cells have a negative consequence 
in survival. We performed clonogenic assays both in 
hamster and human cells (Figure 6A–6B). As can be seen, 
CSB mutant cells (UV61 and CS1AN) presented reduced 
survival when exposed to 5-azadC. In good agreement 
with this, CSB mutant cells also showed a reduced growth 
when they were chronically exposed to 5-azadC (Figure 
6C–6D). Cell cycle profiles agree very well with the above 
data and showed increased levels of cell death (sub-G1 
cells) in CSB mutant cells when treated with 5-azadC 
(Figure 6E–6H).
Figure 3: CSB mutant cells have defects in the signaling of the initial DNA damage induced by 5-azadC. (A-B) Similar 
levels of trapped DNMT1 in wild type AA8 and CSB defective UV61 cells. DNMT1 CSB-GFP cells were treated for 6 h with 15μM of 
5-azadC, fixed and prepared for scoring of DNMT1 foci. Cells > 5 foci were scored as positive (A). Alternatively the number of DNMT1 
foci/cell is also represented (B). (C) CSB cells have defects forming γ-H2AX foci in response to a short 5-azadC treatment (6 h). (D) 
5-azadC induces DNMT1-γH2AX co-localization in a CSB dependent fashion. DNMT1-GFP transfected cells were treated for 6 h with 
5-azadC, fixed and immunolabelled for γH2AX. Mander’s co-localization index was employed (Image J). (E and F) Importance of CSB in 
the formation of γ-H2AX and 53BP1 foci in human cells. CS1AN and CS1AN CSB-GFP cells were treated for 6 h with 5-azadC (15μM), 
fixed and immunolabelled for the indicated proteins. A clear increase in foci was observed for complemented cells. However CSB cells 
couldn’t form repair foci. (G) CSB cells present transcription blocks after a short treatment with 5-azadC. AA8 and UV61 cells were treated 
with increasing doses of 5-azadC for 6 h and labelled with tritiated uridine for 15 minutes in order to monitor transcription rates. CSB cells 
presented blocks in transcription elongation from the first dose assayed. However for wild type cells blocks are evident only for higher 
doses assayed.
Oncotarget35075www.oncotarget.com
Transcription and CSB work in the same 
pathway to promote survival after treatment 
with 5-azadC
Apart from TC-NER, CSB has been implicated 
in several processes such as Base Excision Repair [11, 
32, 33], nucleosome positioning [34] and mitochondrial 
DNA repair [35]. As far as we know, many of these 
processes are not closely related to transcription 
elongation. Therefore, we analyzed if the function of CSB 
is epistatic with transcription elongation in response to 
5-azadC. We treated AA8 and UV61 cells with 5-azadC 
for 24 h. During the last 12 h cells were cultured in the 
presence/absence of the transcription inhibitors DRB or 
Figure 4: Delayed repair of trapped DNMT1 in CSB mutant cells. (A) Validation of the fractionation protocol followed. AA8 
and UV61 cells were transfected with DNMT1-GFP plasmid before lysis. Whole (W) or fractionated lysis were carried out. Cytoplasmic 
(Cyt), nuclear soluble (Nu.sol.) and chromatin (Chr.) fractions were obtained. Our data show that endogenous and ectopic DNMT1 are 
equally expressed in both cell types. The expected localization of GADPH, Fibrillarin and γ-H2AX in the cytosolic, nuclear, and chromatin 
enriched fractions, respectively is shown. (B) Repair of chromatin bound DNMT1-GFP in wild type AA8 and CSB deficient UV61 cells. 
Cells were treated for 24h with 15μM of 5-azadC and allowed to repair in drug free media for the indicated times. Cells were fractionated 
and chromatin fractions were loaded analyzed by SDS-PAGE. (C) A densitometric analysis of the chromatin bound DNMT1-GFP in relation 
to the chromatin marker H3 is shown. (D) Alternatively DNMT1-GFP transfected AA8 and UV61 cells were treated for 24h with 15μM of 
5-azadC and allowed to repair in drug free media for different times, fixed and scored for DNMT1 foci in a fluorescence microscope. The 
means and SEM of two independent experiments are shown. Data were considered statistically different when P < 0.05 (*) or P < 0.01(**).
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α-Amanitin. Next, we monitored DNA repair foci (Figure 
7A–7C) or micronuclei (Figure 7D) induction. An increase 
of DNA repair foci induced by 5-azadC was observed 
when transcription was blocked in wild type cells but 
not in UV61 cells (Figure 7A–7C). The same pattern was 
observed when looking at micronuclei induction (Figure 
7D). The lack of potentiation in micronuclei induction 
in CSB deficient cells cannot be explained by a delay in 
cell cycle, as no difference in the progression of the cell 
cycle was observed (Supplementary Figure 2). Overall 
Figure 5: Increased levels of DNA damage in CSB mutant cells after a prolongued 5-azadC treatment. (A–D) AA8 
and UV61 cells were treated for 24 h with 5-azadC (2μM) washed and allowed to repair for 24h. Then were fixed and prepared for 
immunological staining of γ-H2AX (A-B), 53BP1 (C) and RAD51 (D). (E) In order to monitor residual DNA damage after a 24h treatment 
with 5-azadC, we performed micronucleus assay. Cells were treated with increasing doses of 5-azadC, washed and allowed to repair 
in cytochalasin B containing media for 18h. Cells were then fixed and scored for the number of micronuclei in binucleated cells. The 
means and SEM of three independent experiments are shown. Data were statistically analysed using Student’s t-test. Data were considered 
statistically different when P < 0.05 (*) or P < 0.01(**).
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these results suggest that transcription works in the same 
pathway than CSB to repair lesions induced by 5-azadC.
Finally, we wanted to see if the epistatic interaction 
could be also observed when looking at cell survival 
(Figure 7E). In good agreement with the data presented 
above, a clear sensitization by DRB was obtained just in 
wild type cells. As a whole, data suggest that transcription 
works upstream to CSB in response to lesions induced by 
5-azadC.
DISCUSSION
Several DNA damaging agents are known to form 
DNA-protein cross-links (DPC), including topoisomerase 
I and II poisons, 5-azadC, PARP inhibitors and cisplatin. 
In recent years, some mechanisms involved in the repair 
of these DNA insults have been elucidated [36], although 
many questions remains unanswered for the DPC induced 
by 5-azadC.
Figure 6: CSB promotes survival after 5-azadC incorporation. (A and B) Survival after 5-azadC treatments. AA8 and UV61 
cells (A) or CS1AN and CS1AN CSB-GFP cells (B) were seeded at low density, treated with 5-azadC for 24h and allowed to repair in fresh 
media for 7-9 days to form colonies. Colonies were fixed and stained with methylene blue/methanol 4 g/L. Colonies with more than 50 
cells were scored. Data are plotted in relation to the survival of control cells (100 %). (C and D) Cell growth after a continuous exposure to 
5-azadC (15μM). Cells were collected at the indicated times and viable cells were scored (tripan blue negative). (E–H) Cell cycle profiles 
after a continuous exposure to 5-azadC (15μM) in AA8-UV61 (E), CS1AN-CS1AN CSB-GFP (F) and quantifications of subG1 cells (G-H). 
The means and SEM of three independent experiments are shown. Data were statistically analized using Student’s t-test. Data were 
considered statistically different when P < 0.05 (*) or P < 0.01(**).
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Immobilized proteins onto DNA are described to 
be very effective disruptors of transcription [37], and 
are preferentially repaired if they are in the transcribed 
strand [38]. The arrest of RNApol II at transcription 
blocking lesions stops the elongation of the newly 
synthesized RNA and if the block is prolonged in time, 
leads into apoptosis.
It has been shown that transcription blocks trigger a 
different ATM-dependent DNA damage response named 
non-canonical ATM activation [24, 25, 39]. In this paper 
Figure 7: Prolonged transcription inhibition potentiates 5-azadC-induced DNA damage in a CSB dependent manner. 
(A–C) Cells were treated for 24h with 5-azadC (2μM), DRB (10μM) was added in the last 12h. Cells were then fixed and immunomarked 
for γ-H2AX (A), 53BP1 (B) and RAD51 (C). (D) DNA damage was also scored with the micronucleus test. Exponential cell cultures 
were treated 5-azadC (15 μM) alone or in combination with DRB (20μM) or α-Amanitin (1μM) and allowed to recover in cytochalasin 
B containing media for 18h, fixed and the frequency of micronucleus was scored in binucleated cells. The means and SEM of three 
independent experiments are shown. Data were statistically analyzed using Student’s t-test. Data were considered statistically different 
when P < 0.05 (*) or P < 0.01(**). (E) Transcription inhibition sensitizes wild type cells but not CSB deficient cells to 5-azadC. AA8 and 
UV61 cells were seeded at low density and 4h later treated for 36h with increasing doses of 5-azadC. Last 24h cells were in the presence of 
DRB (20μM). Cells were then washed and allowed to form colonies in drug free media for 7-9 days. Colonies were then fixed and stained 
with methylene blue in methanol (4g/L). Data are plotted as percentage of survival in relation to control cells (100 %). A representative 
experiment is shown.
Oncotarget35079www.oncotarget.com
we designed a 6 hour schedule to monitor the initial events 
in the repair of trapped DNMT1 by 5-azadC. Under these 
conditions we assume that the canonical ATM response 
that arises when replication forks are collapsed with 
trapped DNMT1 is not activated [40].
Firstly we demonstrate that a short treatment with 
5-azadC induces either DNA breaks (Figure 1) and repair 
foci (Figure 2) in a transcription dependent manner. As far 
as we know this is the first demonstration that a TC-DDR 
is activated soon after trapping of DNMT1. These repair 
foci including γ-H2AX and 53BP1 depends on functional 
CSB to be established, as no induction of foci was found 
when CSB deficient cells were treated for a short time with 
5-azadC (Figure 3A–3F). Furthermore, we demonstrate 
that the treatment with 5-azadC for a short time, decreases 
the transcription rates of CSB mutant cells (Figure 3G), 
which suggests that transcription in mutant cells cannot 
be resumed after 5-azadC treatment. Similarly, a lack of 
53BP1 and γ-H2AX foci induction was found when CSB 
deficient cells were treated for a short time with CPT [41] 
or Ecteinascidin 743 [42] respectively. Both drugs are well 
known inductors of transcription coupled DNA damage. 
However, there is another recent contribution where it is 
shown that the levels of 53BP1 foci are increased in CSB 
deficient cells soon after a ionizing radiation exposure 
[15]. A plausible explanation to this controversy could 
be the different implications of TC-DDR in relation with 
the agents studied. It is likely that the role of CSB when 
recruited to IR-induced DSBs differs from its implication 
in bulky lesions such as those induced by Ecteinascidin 
743, Topoisomerase I poisons or 5-azadC.
When RNApol II is stalled at damage sites, a 
CSB-dependent recruitment of CSA/E3 ubiquitin ligase 
complex is followed by the recruitment of other NER 
factors [43]. However, classic NER proteins do not seem 
to be important in survival after 5-azadC exposure, so the 
repair mechanism behind DNMTs-DNA adducts is not a 
classical TC-NER (see reference [44] and Supplementary 
Figure 3).
We also show an increase in the colocalization 
levels between DNMT1 and γ-H2AX when exposed for 
a short time to 5-azadC in wild type cells, which indicates 
that the activated DDR is related to trapped DNMT1 
(Figure 2F and 3D). In support of this notion, we show 
a delayed repair of trapped DNMT1 in CSB deficient 
cells (Figure 4). Future work is needed to elucidate the 
exact mechanism of this repair; however it is interesting 
to mention that CSB contains a PARP binding site and 
that there is epistatic evidence that PARP1 and CSB act 
together in repair of oxidative lesions [45]. Interestingly, 
we have reported that the PARP inhibitor Olaparib delays 
the clearance of DNMT1 foci after 5-azadC [22]; we can 
Figure 8: Proposed model of CSB in the toxicity of 5-azadC. 5-azadC is randomly incorporated instead of normal cytosine during 
DNA replication and attempted to be methylated at inter- and intragenic CpG islands by DNMT1 which remain trapped generating protein-
DNA adducts. Transcription forks are blocked at these adducts generating DNA DSBs that need to be properly signaled in a CSB dependent 
manner. CSB proficient cells are able to repair the adducts but not CSB deficient cells. If these adducts are not repaired, they could interfere 
with the progression of the replication forks of the following cell cycle and generate DSBs and cell death.
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speculate that PARP and CSB are working in an epistatic 
fashion to repair these DNA lesions.
Apart from protein-DNA adducts, 5-azadC also 
induces base damage that can be converted into single 
strand breaks (SSB) after BER processing [22] and 
SSB can also be a strong block to transcription [46]. 
As 5-azadC is incorporated all over the genome but 
concentrated in CpG islands, it is possible that clustered 
lesions (comprised by SSB and trapped DNMTs) can be 
formed in those islands and transcription could be stopped 
by both types of lesions.
DNA methylation is key epigenetic mechanisms 
consisting on the covalent addition of a methyl group 
to the carbon at position 5 of the cytosine in the CpG 
dinucleotides. Around 80% of methylation occurs at CpG 
sites in mammalian genomes [47]. These palindromic 
dinucleotides are concentrated in regions called CpG 
islands, that can be found both in gene promoters as well 
as in gene bodies, where they can regulate splicing [48] 
and expression of noncoding RNAs [49]. Single CpGs are 
often found in repetitive DNA elements and centromeric 
regions that are not related to transcription.
During replication, methylation pattern is 
maintained by DNMT1 [50]. This 180 kDa enzyme 
methylates hemimethylated DNA acting just after 
replication forks. 5-azadC is randomly incorporated into 
DNA instead of normal cytosine. Therefore, DNMTs could 
be trapped either in islands surrounding the transcription 
start site as well as in intragenic islands. We think that the 
transcription fork could be blocked with the incorporation 
of DNMT1-DNA adducts in those places triggering a 
DDR.
When 5-azadC is administered for prolonged 
periods (24 h), we found higher levels of DNA repair 
foci in CSB deficient cells (Figure 5). Increased levels 
of 53BP1 and RIF1, as well as reduced levels of RAD51 
foci, have been found in CSB deficient cells treated with 
ionizing radiation. These data support an active role of 
CSB in the DSB repair pathway choice: facilitating HR 
and suppressing Non-Homologous-End-Joining (NHEJ) 
[15]. After a 5-azadC treatment, we found higher levels 
of γ-H2AX and 53BP1 foci, as well as increased levels 
of RAD51 foci, which suggests that HR is not impaired 
in our CSB deficient cells. We believe that foci arising 
after long 5-azadC treatments differ from those observed 
when 5-azadC is present only for 6 h. We hypothesize that 
a short treatment schedule reveals only the initial DNA 
damage repair, i.e., transcription coupled repair of trapped 
DNMTs. However, when long treatment schedules were 
assayed, both repair of trapped DNMTs and its collisions 
with replications forks (probably occurring at the same 
time) are visualized. The reduced levels of the initial repair 
foci in CSB deficient cells are explained by a possible role 
of CSB in a DDR response after transcription blocks. If 
CSB is not functional, then more unrepaired lesions are 
present in DNA which can interfere with second round 
replication forks, leading to more DBSs with time.
All data compiled in this paper can be summarized 
as follows (Figure 8). While replication forks advance, 
DNMT1 methylates cytosines present in CpG sites. When 
5-azadC is in the place of normal cytosine, DNMT1 
remains trapped generating DNA damage. These bulky 
lesions block transcription forks and generate DNA 
breaks. According to our data, CSB orchestrates a DDR 
of these lesions. If cells have functional CSB, then a 
proper DNA damage response is activated and DNA repair 
proteins are recruited; this allows repair and resumption of 
transcription. In the absence of CSB, DNA adducts are not 
repaired and could represent an obstacle to next replication 
and as a consequence DNA breaks and cell death.
MATERIALS AND METHODS
Cell culture and chemicals
Chinese hamster ovary cells AA8 (wild-type) and 
UV61 (CSB deficient) were a gift from Larry Thompson 
and were cultured in DMEM media. The human CSB 
(ERCC6) gene corrects the transcription coupled repair 
defect in UV61 cells [51].
CS1AN cells are SV40 immortalized patient 
fibroblasts deficient in CSB and were a gift from 
Jurgen Marteijn (Erasmus MC, Department of Genetics, 
Wytemaweg 80 3015 CN Rotterdam). These cells were 
complemented with CSB-GFP [52].
All cell lines were cultured with 10% fetal bovine 
serum, penicillin (50 U/ml) and streptomycin (50 μg/ml), 
at 37°C in a 5% CO2 atmosphere.
5-aza-2′-deoxycytidine (Sigma) was dissolved in 
phosphate buffered saline (PBS), aliquoted and stored at 
−80°C. 5,6-Dichlorobenzimidazole 1-β-D-ribofuranoside 
(DRB), α-Amanitin and Cytochalasin B (Cyt B) were 
obtained from Sigma, dissolved in DMSO, aliquoted 
and stored at −80°C. DRB inhibits CK2 kinase which 
phosphorylates and activates RNA polymerase II, resulting 
in repression of transcription elongation [53] and dramatic 
reduction in mRNA levels [54].
Immunofluorescence
Exponential growing cells were treated for 24 h with 
5-azadC. During the last 12 h of this treatment cultures 
were grown in the presence or absence of DRB (10μM).
Alternatively, cells were treated with 5-azadC 
(15μM) for 6 h and DRB (30μM) was present during the 
last 3 h.
After treatments, cells were washed in PBS and 
incubated for 30s with ice cold 0.1% PBS containing 
Triton-X in order to pre-extract soluble protein. Then cells 
were fixed in 4% paraformaldehyde at room temperature 
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for 10 min. Immunofluorescence of γ-H2AX (millipore), 
53BP1 (Santa Cruz) and RAD51 (Santa Cruz) were carried 
out as previously described (21). Cells were photographed 
using a Zeiss LSM 7 duo confocal microscope.
The number of foci per cell was assessed using 
Image J software (NIH). Also, the percentage of cells with 
more than 10 or 20 foci were scored. At least 200 nuclei 
were counted on each slide.
Plasmids and transfection procedures
The plasmid expressing GFP-tagged DNMT1 
was a gift from Keith Robertson and has been described 
previously [20].
All transient transfections were performed using 
JetPRIME® transfection reagent according to the 
manufacturer’s protocol (PolyPlus). Cells were allowed 
to express DNMT1-GFP for 24 h, cells were then 
treated with 5-azadC (15μM) for 6 h and fixed using 4% 
paraformaldehyde. Samples were then processed for the 
detection of γ-H2AX foci according to previous papers 
(21). Manders colocalization index was measured using 
Fiji software (Coloc2 plugin, where 1 means perfect co-
localization and 0 no co-localization).
For repair experiments, 24 h after DNMT1-
GFP transfection, cells were trypsinized reseeded and 
treated with 5-azadC (15μM) for 24 h. Media was then 
replaced and cells were fixed at different times using 
paraformaldehyde 4%. The percentage of cells with > 10 
DNMT1 foci in transfected cells was scored [22].
Survival assay
Cells were seeded at low density in 10 cm Petri 
dishes 4h prior to 5-azadC treatment for 24h. Media was 
then replaced and colonies were allowed to grow for 8–10 
days.
For combination experiments cells were treated for 
12 h with increasing doses of 5-azadC. Then DRB (20μM) 
was added to the cultures for 24 h. At this point media was 
replaced and colonies were allowed to grow for 8-10 days.
Colonies were then fixed and stained (methylene 
blue dissolved in methanol, 4g/l). The data are plotted as 
percentage of survival referred to control cells.
Micronucleus assay
Cells were seeded and allowed to grow for 24 h. 
Next day, cultures were treated with increasing doses of 
5-azadC for another 24 h. For combined experiments, 
cells were treated for 12 h with 5-azadC, media was then 
replaced and cells were allowed to grow in the presence 
of the transcription inhibitors α-Amanitin (1μM) or DRB 
(20μM) for 12 h.
Finally, for all experiments, media was changed and 
cultures were treated with 3 μg/ml of Cytochalasin B for 
18 h. Cells were trypsinized and fixed in methanol-acetic 
solution (3:1). Preparations were made by dropping cells 
onto wet slides and staining with Giemsa (3% in Sörensen 
buffer). Two thousand binucleated cells were scored for 
micronucleus frequency in each treatment.
Chromosome analysis
Exponential growing AA8 and UV61 cells were 
cultured for 6 h with 5-azadC (50μM). DRB (30μM) was 
added during the last 3 h. Then mitotic arrest was achieved 
with 2×10−7 M of colcemid for 2.5h.
Cells were collected and incubated in hypotonic 
solution (0.075M KCl) for 2 min, fixed in methanol: acetic 
acid (3:1) and dropped onto microscope slides. Slides 
were stained with 3% Giemsa/Sörensen’s buffer for 5 min 
and mounted in D.P.X. (Sigma).
Two hundred complete metaphases were evaluated 
in each experimental point. Images were taken with a 
Nikon eclipse 50i microscope equipped with a Nikon 
DS-Fi1 camera and using the 100-fold magnification 
objective (numerical aperture 1.25) and the NIS Elements 
3.0 adquisition software (Nikon).
Cellular fractionation and SDS-PAGE analysis
In order to measure the trapping and repair of 
DNMT1 in DNA, we performed cellular fractionation 
as described before [22, 55]. After treatment, cells were 
collected at different time points and counted separately 
using a Bio-Rad TC20™ cell counter. In order to load 
equal amounts of chromatin fractioned protein, 1×106 
cells were fractioned for each sample. All protein were 
separated on sodium dodecylsulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE) gels and subsequently 
transferred to nitrocellulose membranes. All subsequent 
steps were carried out in TBS–Tween (10 mM Tris-
HCl, pH7.6, 150mM NaCl and 0.05% Tween-20) either 
containing 5% milk (blocking and antibody incubations) 
or 5% BSA (phospho-specific antibody incubations). 
Antibody binding was visualized by enhanced 
chemiluminescence using the SuperSignal West Dura or 
Pico reagents from Pierce™. Antibodies used: DNMT1 
(Abcam), Histone H3 (Santa Cruz), GAPDH (Abcam) and 
Fibrilarin (Santa Cruz).
Transcription assay
In order to measure transcription rates we seeded 
50.000 AA8/UV61 cells in 24 well plates. After 24h, they 
were treated with increasing doses of 5-azadC. 6 h later, 
1μCi of [3H]-Uridine was added for 15 minutes at 37°C, 
washed once with PBS and ice cold-methanol extracted 
for 30 minutes. Cells were washed again with PBS and 
500μl of 0.01M NaPO4H3 in 0.5% SDS buffer was added. 
Cells were then dislodged with a cell scraper, transferred 
to 1.5 ml tubes and sonicated in water bath for 10 minutes. 
Finally lysates were transferred to scintillation tubes and 
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3ml of Ultima Gold scintillation fluid were added before 
analysis.
Flow cytometry
Exponential cells were treated with 5-azadC (15 
μM) and collected at different time points. Then cells 
were counted and cell viability was monitored using 
trypan blue exclusion assay. Cells were washed in ice-
cold PBS and fixed in 70% ethanol for 24h at –20°C. 
Subsequently, cells were washed and incubated with 500μl 
of a solution containing Propidium iodide (0.1 mg/ml) and 
RNAse (8 μg/ml) for 1.5 h at 4°C. Cell cycle profiles were 
obtained in a Beckman Coulter Flow cytome ter model: 
CYTOMICS FC500-MPL.
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